Logitech Announces Q4 and Full Fiscal Year 2025 Results
29.4.2025 22:03:00 CEST | Business Wire | Press Release
SIX Swiss Exchange Ad hoc announcement pursuant to Art. 53 LR — Logitech International (SIX: LOGN) (Nasdaq: LOGI) today announced financial results for the fourth quarter and full Fiscal Year 2025 ended March 31, 2025.
For Fiscal Year 2025:
- Sales were $4.55 billion, up 6 percent in US dollars and 7 percent in constant currency, compared to the prior year.
- GAAP operating income was $655 million, up 11 percent compared to the prior year. Non-GAAP operating income was $775 million, up 11 percent compared to the prior year.
- GAAP earnings per share (EPS) was $4.13, up 7 percent compared to the prior year. Non-GAAP EPS was $4.84, up 14 percent compared to the prior year.
- Cash flow from operations was $843 million. The year-ending cash balance was $1.5 billion. The Company returned $797 million of cash to shareholders through its annual dividend payment and share repurchases.
For Q4 Fiscal Year 2025:
- Sales were $1.01 billion, flat in US dollars and up 2 percent in constant currency, compared to Q4 of the prior year.
- GAAP operating income was $106 million, down 19 percent, compared to Q4 of the prior year. Non-GAAP operating income was $133 million, down 16 percent, compared to Q4 of the prior year. This was due to a bad debt expense and strategic investments made in the quarter.
- GAAP earnings per share (EPS) was $0.96, down 10 percent compared to Q4 prior year. Non-GAAP EPS was $0.93, down 6 percent compared to the prior year.
- Cash flow from operations was $130 million.
“Fiscal Year 2025 was an outstanding year of broad-based sales growth, driven by our strategic priorities,” said Hanneke Faber, Logitech chief executive officer. “Thanks to our diverse global footprint, strong brand and resilient operations, we are in a strong position to navigate the unpredictable market conditions ahead in Fiscal Year 2026. In this dynamic environment, we will focus on three core principles - playing offense, disciplined cost control and agility.”
“Our teams executed impressively once again this Q4, completing a year of strong operational discipline,” said Matteo Anversa, Logitech chief financial officer. “We closed Fiscal Year 2025 with robust growth across all regions, customer channels and in nearly all our categories. Our growth continued to be extremely profitable, with non-GAAP gross margins at 43.5%. We were pleased to return $797 million of cash to shareholders in the year.”
Outlook
Earlier this month, Logitech communicated that the Company has withdrawn its outlook for Fiscal Year 2026 due to the continuing uncertainty surrounding the tariff environment. The Company today announced an outlook for Q1 FY 2026:
Q1 FY26 outlook | |
Sales | $1,100 - $1,150 million |
Sales growth (in US dollars, year over year) | 1% - 6% |
Sales growth (in constant currency, year over year) | 0% - 5% |
Non-GAAP operating income | $155 - $185 million |
Non-GAAP op. inc. growth/(decline) (year over year) | (15%) - 1% |
Financial Results Videoconference and Webcast
Logitech will hold a financial results videoconference to discuss the results for Q4 and the full Fiscal Year 2025 on Tuesday, April 29, 2025 at 1:30 p.m. Pacific Daylight Time (PDT) and 10:30 p.m. Central European Summer Time (CEST).
A livestream of the event will be available on the Logitech corporate website at https://ir.logitech.com. This press release and the Q4 Fiscal Year 2025 Shareholder Letter are also available there.
Use of Non-GAAP Financial Information and Constant Currency
To facilitate comparisons to Logitech’s historical results, Logitech has included non-GAAP adjusted measures in this press release, which exclude share-based compensation expense, amortization and impairment of intangible assets, acquisition-related costs, restructuring charges (credits), net, change in fair value of contingent consideration for business acquisition, loss (gain) on investments, non-GAAP income tax adjustment, and other items detailed under “Supplemental Financial Information” after the tables below and posted to our website at https://ir.logitech.com. Logitech also presents percentage sales growth in constant currency (“cc”), a non-GAAP measure, to show performance unaffected by fluctuations in currency exchange rates. Percentage sales growth in constant currency is calculated by translating prior period sales in each local currency at the current period’s average exchange rate for that currency and comparing that to current period sales. Logitech believes this information, used together with the GAAP financial information, will help investors to evaluate its current period performance and trends in its business. With respect to the Company’s outlook for non-GAAP operating income, most of the excluded amounts pertain to events that have not yet occurred and are not currently possible to estimate with a reasonable degree of accuracy. Therefore, no reconciliation to the GAAP amounts has been provided for the first quarter of Fiscal Year 2026 non-GAAP outlook.
Public Dissemination of Certain Information
Recordings of Logitech’s earnings videoconferences and certain events Logitech participates in or hosts, with members of the investment community are posted on the company’s investor relations website at https://ir.logitech.com. Additionally, Logitech provides notifications of news or announcements regarding its operations and financial performance, including its filings with the Securities and Exchange Commission (SEC), investor events, and press and earnings releases as part of its investor relations website. Logitech intends to use its investor relations website as means of disclosing material nonpublic information and for complying with its disclosure obligations under Regulation FD. Logitech’s corporate governance information also is available on its investor relations website.
About Logitech
Logitech designs software-enabled hardware solutions that help businesses thrive and bring people together when working, creating and gaming. As the point of connection between people and the digital world, our mission is to extend human potential in work and play, in a way that is good for people and the planet. Founded in 1981, Logitech International is a Swiss public company listed on the SIX Swiss Exchange (LOGN) and on the Nasdaq Global Select Market (LOGI). Find Logitech and its other brands, including Logitech G, at www.logitech.com or company blog.
This press release contains forward-looking statements within the meaning of U.S. federal securities laws, including, without limitation, statements regarding: our preliminary financial results for the three months and fiscal year ended March 31, 2025, opportunities for growth, and related assumptions. The forward-looking statements in this press release are subject to risks and uncertainties that could cause Logitech’s actual results and events to differ materially from those anticipated in these forward-looking statements, including, without limitation: macroeconomic and geopolitical conditions and other factors and their impact, for example inflation, interest rate and foreign currency fluctuations, changes in fiscal policies, geopolitical conflicts, low economic growth in certain regions, and uncertainty in consumer and enterprise demand; changes in trade regulations, policies and agreements and the imposition of tariffs that affect our products or operations, including potential new tariffs that may be imposed on U.S. imports and our ability to mitigate; our expectations regarding our expense discipline efforts, including the timing thereof; changes in secular trends that impact our business; if our product offerings, marketing activities and investment prioritization decisions do not result in the sales, profitability or profitability growth we expect, or when we expect it; if we fail to innovate and develop new products in a timely and cost-effective manner for our new and existing product categories; issues relating to development and use of artificial intelligence; if we do not successfully execute on our growth opportunities or our growth opportunities are more limited than we expect; the effect of demand variability, supply shortages and other supply chain challenges; the effect of logistics challenges, including disruptions in logistics; the effect of pricing, product, marketing and other initiatives by our competitors, and our reaction to them, on our sales, gross margins and profitability; if we are not able to maintain and enhance our brands; if our products and marketing strategies fail to separate our products from competitors’ products; if we do not efficiently manage our spending; our expectations regarding our restructuring efforts, including the timing thereof; if there is a deterioration of business and economic conditions in one or more of our sales regions or product categories, or significant fluctuations in exchange rates; if we do not successfully execute on strategic acquisitions and investments; risks associated with acquisitions; and the effect of changes to our effective income tax rates. A detailed discussion of these and other risks and uncertainties that could cause actual results and events to differ materially from such forward-looking statements is included in Logitech’s periodic filings with the Securities and Exchange Commission (“SEC”), including our Annual Report on Form 10-K for the fiscal year ended March 31, 2024, our Quarterly Report on Form 10-Q for the quarter ended December 31, 2024, and other reports filed with the SEC, available at www.sec.gov, under the caption Risk Factors and elsewhere. Logitech does not undertake any obligation to update any forward-looking statements to reflect new information or events or circumstances occurring after the date of this press release.
Note that unless noted otherwise, comparisons are year over year.
Logitech and other Logitech marks are trademarks or registered trademarks of Logitech Europe S.A. and/or its affiliates in the U.S. and other countries. All other trademarks are the property of their respective owners. For more information about Logitech and its products, visit the company’s website at www.logitech.com.
LOGITECH INTERNATIONAL S.A. | ||||||||||||||||
PRELIMINARY RESULTS* | ||||||||||||||||
(In thousands, except per share amounts) - unaudited | ||||||||||||||||
Three Months Ended | Fiscal Years Ended | |||||||||||||||
March 31, | March 31, | |||||||||||||||
GAAP CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | 2025 | 2024 | 2025 | 2024 | ||||||||||||
Net sales | $ | 1,010,355 | $ | 1,011,487 | $ | 4,554,900 | $ | 4,298,467 | ||||||||
Cost of goods sold | 572,334 | 572,051 | 2,582,745 | 2,509,418 | ||||||||||||
Amortization of intangible assets | 2,210 | 2,459 | 9,554 | 11,028 | ||||||||||||
Gross profit | 435,811 | 436,977 | 1,962,601 | 1,778,021 | ||||||||||||
Operating expenses: | ||||||||||||||||
Marketing and selling | 198,598 | 185,594 | 814,414 | 730,310 | ||||||||||||
Research and development | 79,523 | 75,421 | 309,008 | 287,243 | ||||||||||||
General and administrative | 40,266 | 38,510 | 164,014 | 155,056 | ||||||||||||
Amortization of intangible assets and acquisition-related costs | 2,630 | 2,655 | 10,695 | 10,934 | ||||||||||||
Impairment of intangible assets | — | 3,526 | — | 3,526 | ||||||||||||
Change in fair value of contingent consideration for business acquisition | — | (250 | ) | — | (250 | ) | ||||||||||
Restructuring charges, net | 8,890 | 1,304 | 9,615 | 3,866 | ||||||||||||
Total operating expenses | 329,907 | 306,760 | 1,307,746 | 1,190,685 | ||||||||||||
Operating income | 105,904 | 130,217 | 654,855 | 587,336 | ||||||||||||
Interest income | 12,394 | 16,128 | 54,997 | 50,636 | ||||||||||||
Other income (expense), net | (91 | ) | (2,549 | ) | (2,980 | ) | (16,376 | ) | ||||||||
Income before income taxes | 118,207 | 143,796 | 706,872 | 621,596 | ||||||||||||
Provision for (benefit from) income taxes | (25,859 | ) | (23,819 | ) | 75,343 | 9,453 | ||||||||||
Net income | $ | 144,066 | $ | 167,615 | $ | 631,529 | $ | 612,143 | ||||||||
Net income per share: | ||||||||||||||||
Basic | $ | 0.97 | $ | 1.09 | $ | 4.17 | $ | 3.90 | ||||||||
Diluted | $ | 0.96 | $ | 1.07 | $ | 4.13 | $ | 3.87 | ||||||||
Weighted average shares used to compute net income per share: | ||||||||||||||||
Basic | 148,999 | 154,452 | 151,322 | 156,776 | ||||||||||||
Diluted | 150,709 | 156,204 | 152,784 | 158,171 | ||||||||||||
LOGITECH INTERNATIONAL S.A. | ||||||||
PRELIMINARY RESULTS* | ||||||||
(In thousands, except per share amounts) - unaudited | ||||||||
March 31, | March 31, | |||||||
CONDENSED CONSOLIDATED BALANCE SHEETS | 2025 | 2024 | ||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 1,503,205 | $ | 1,520,842 | ||||
Accounts receivable, net | 454,546 | 541,715 | ||||||
Inventories | 503,747 | 422,513 | ||||||
Other current assets | 131,211 | 146,270 | ||||||
Total current assets | 2,592,709 | 2,631,340 | ||||||
Non-current assets: | ||||||||
Property, plant and equipment, net | 113,858 | 116,589 | ||||||
Goodwill | 463,230 | 461,978 | ||||||
Other intangible assets, net | 24,630 | 44,603 | ||||||
Other assets | 344,077 | 350,194 | ||||||
Total assets | $ | 3,538,504 | $ | 3,604,704 | ||||
Current liabilities: | ||||||||
Accounts payable | $ | 414,586 | $ | 448,627 | ||||
Accrued and other current liabilities | 686,503 | 637,262 | ||||||
Total current liabilities | 1,101,089 | 1,085,889 | ||||||
Non-current liabilities: | ||||||||
Income taxes payable | 88,483 | 112,572 | ||||||
Other non-current liabilities | 221,512 | 172,590 | ||||||
Total liabilities | 1,411,084 | 1,371,051 | ||||||
Shareholders' equity: | ||||||||
Registered shares, CHF 0.25 par value Issued shares: 168,994 and 173,106 at March 31, 2025 and 2024, respectively | 29,432 | 30,148 | ||||||
Additional paid-in capital | 82,591 | 63,524 | ||||||
Shares in treasury, at cost — 20,485 and 19,243 shares at March 31, 2025 and 2024, respectively | (1,464,912 | ) | (1,351,336 | ) | ||||
Retained earnings | 3,627,261 | 3,602,519 | ||||||
Accumulated other comprehensive loss | (146,952 | ) | (111,202 | ) | ||||
Total shareholders' equity | 2,127,420 | 2,233,653 | ||||||
Total liabilities and shareholders' equity | $ | 3,538,504 | $ | 3,604,704 | ||||
LOGITECH INTERNATIONAL S.A. | ||||||||||||||||
PRELIMINARY RESULTS* | ||||||||||||||||
(In thousands) - unaudited | ||||||||||||||||
Three Months Ended | Fiscal Years Ended | |||||||||||||||
March 31, | March 31, | |||||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | 2025 | 2024 | 2025 | 2024 | ||||||||||||
Cash flows from operating activities: | ||||||||||||||||
Net income | $ | 144,066 | $ | 167,615 | $ | 631,529 | $ | 612,143 | ||||||||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||||||
Depreciation | 15,486 | 14,191 | 59,664 | 63,065 | ||||||||||||
Amortization of intangible assets | 4,840 | 5,098 | 20,098 | 21,681 | ||||||||||||
Impairment of intangible assets | — | 3,526 | — | 3,526 | ||||||||||||
Loss on investments | 311 | 2,461 | 2,029 | 14,674 | ||||||||||||
Share-based compensation expense | 13,846 | 18,697 | 89,913 | 82,889 | ||||||||||||
Deferred income taxes | 37,891 | (32,909 | ) | 56,543 | (42,424 | ) | ||||||||||
Change in fair value of contingent consideration for business acquisition | — | (250 | ) | — | (250 | ) | ||||||||||
Other | (10 | ) | 43 | 120 | 379 | |||||||||||
Changes in assets and liabilities, net of acquisitions: | ||||||||||||||||
Accounts receivable, net | 197,913 | 138,305 | 69,979 | 91,519 | ||||||||||||
Inventories | (12,947 | ) | 21,827 | (80,501 | ) | 259,796 | ||||||||||
Other assets | 14,554 | 7,062 | 23,970 | 10,760 | ||||||||||||
Accounts payable | (168,475 | ) | (81,047 | ) | (31,627 | ) | 39,336 | |||||||||
Accrued and other liabilities | (117,819 | ) | (25,514 | ) | 840 | (11,978 | ) | |||||||||
Net cash provided by operating activities | 129,656 | 239,105 | 842,557 | 1,145,116 | ||||||||||||
Cash flows from investing activities: | ||||||||||||||||
Purchases of property, plant and equipment | (12,788 | ) | (10,312 | ) | (56,128 | ) | (55,897 | ) | ||||||||
Acquisitions, net of cash acquired | — | (286 | ) | — | (14,424 | ) | ||||||||||
Purchases of deferred compensation investments | (798 | ) | (3,678 | ) | (6,600 | ) | (11,571 | ) | ||||||||
Proceeds from sales of deferred compensation investments | 2,121 | 3,981 | 7,079 | 12,174 | ||||||||||||
Other investing activities | (446 | ) | (211 | ) | (1,619 | ) | (617 | ) | ||||||||
Net cash used in investing activities | (11,911 | ) | (10,506 | ) | (57,268 | ) | (70,335 | ) | ||||||||
Cash flows from financing activities: | ||||||||||||||||
Payment of cash dividends | — | — | (207,853 | ) | (182,305 | ) | ||||||||||
Payment of contingent consideration for business acquisition | — | — | (1,245 | ) | (5,002 | ) | ||||||||||
Purchases of registered shares | (125,516 | ) | (127,428 | ) | (588,838 | ) | (504,203 | ) | ||||||||
Proceeds from exercises of stock options and purchase rights | 16,170 | 16,878 | 36,405 | 32,197 | ||||||||||||
Tax withholdings related to net share settlements of restricted stock units | (10,234 | ) | (1,148 | ) | (32,485 | ) | (29,744 | ) | ||||||||
Other financing activities | (1,681 | ) | — | (3,344 | ) | (1,116 | ) | |||||||||
Net cash used in financing activities | (121,261 | ) | (111,698 | ) | (797,360 | ) | (690,173 | ) | ||||||||
Effect of exchange rate changes on cash and cash equivalents | 3,889 | (8,709 | ) | (5,566 | ) | (12,789 | ) | |||||||||
Net increase (decrease) in cash and cash equivalents | 373 | 108,192 | (17,637 | ) | 371,819 | |||||||||||
Cash and cash equivalents at beginning of the period | 1,502,832 | 1,412,650 | 1,520,842 | 1,149,023 | ||||||||||||
Cash and cash equivalents at end of the period | $ | 1,503,205 | $ | 1,520,842 | $ | 1,503,205 | $ | 1,520,842 | ||||||||
LOGITECH INTERNATIONAL S.A. | ||||||||||||||||||
PRELIMINARY RESULTS* | ||||||||||||||||||
(In thousands) - unaudited | ||||||||||||||||||
SUPPLEMENTAL FINANCIAL INFORMATION | ||||||||||||||||||
Three Months Ended | Fiscal Years Ended | |||||||||||||||||
March 31, | March 31, | |||||||||||||||||
NET SALES | 2025 | 2024 | Change | 2025 | 2024 | Change | ||||||||||||
Net sales by product category: | ||||||||||||||||||
Gaming (1) | $ | 261,807 | $ | 273,487 | (4 | )% | $ | 1,338,467 | $ | 1,231,063 | 9 | % | ||||||
Keyboards & Combos | 220,626 | 216,240 | 2 | 882,643 | 821,441 | 7 | ||||||||||||
Pointing Devices | 185,857 | 170,677 | 9 | 788,784 | 742,987 | 6 | ||||||||||||
Video Collaboration | 143,245 | 148,104 | (3 | ) | 626,000 | 609,361 | 3 | |||||||||||
Webcams | 77,948 | 75,952 | 3 | 315,520 | 325,225 | (3 | ) | |||||||||||
Tablet Accessories | 57,954 | 55,808 | 4 | 299,540 | 254,060 | 18 | ||||||||||||
Headsets | 42,672 | 45,455 | (6 | ) | 179,710 | 168,478 | 7 | |||||||||||
Other (2) | 20,246 | 25,764 | (21 | ) | 124,236 | 145,852 | (15 | ) | ||||||||||
Total Net Sales | $ | 1,010,355 | $ | 1,011,487 | — | % | $ | 4,554,900 | $ | 4,298,467 | 6 | % | ||||||
(1) Gaming includes streaming services revenue generated by Streamlabs. | ||||||||||||||||||
(2) Other primarily consists of mobile speakers and PC speakers. | ||||||||||||||||||
LOGITECH INTERNATIONAL S.A. | ||||||||||||||||
PRELIMINARY RESULTS* | ||||||||||||||||
(In thousands, except per share amounts) - unaudited | ||||||||||||||||
SUPPLEMENTAL FINANCIAL INFORMATION | Three Months Ended | Fiscal Years Ended | ||||||||||||||
March 31, | March 31, | |||||||||||||||
GAAP TO NON-GAAP RECONCILIATION (A) | 2025 | 2024 | 2025 | 2024 | ||||||||||||
Gross profit - GAAP | $ | 435,811 | $ | 436,977 | $ | 1,962,601 | $ | 1,778,021 | ||||||||
Share-based compensation expense | 1,348 | 1,938 | 10,021 | 8,004 | ||||||||||||
Amortization of intangible assets | 2,210 | 2,459 | 9,554 | 11,028 | ||||||||||||
Gross profit - Non-GAAP | $ | 439,369 | $ | 441,374 | $ | 1,982,176 | $ | 1,797,053 | ||||||||
Gross margin - GAAP | 43.1 | % | 43.2 | % | 43.1 | % | 41.4 | % | ||||||||
Gross margin - Non-GAAP | 43.5 | % | 43.6 | % | 43.5 | % | 41.8 | % | ||||||||
Operating expenses - GAAP | $ | 329,907 | $ | 306,760 | $ | 1,307,746 | $ | 1,190,685 | ||||||||
Less: Share-based compensation expense | 12,498 | 16,759 | 79,892 | 74,885 | ||||||||||||
Less: Amortization of intangible assets and acquisition-related costs | 2,630 | 2,655 | 10,695 | 10,934 | ||||||||||||
Less: Impairment of intangible assets | — | 3,526 | — | 3,526 | ||||||||||||
Less: Change in fair value of contingent consideration for business acquisition | — | (250 | ) | — | (250 | ) | ||||||||||
Less: Restructuring charges, net | 8,890 | 1,304 | 9,615 | 3,866 | ||||||||||||
Operating expenses - Non-GAAP | $ | 305,889 | $ | 282,766 | $ | 1,207,544 | $ | 1,097,724 | ||||||||
% of net sales - GAAP | 32.7 | % | 30.3 | % | 28.7 | % | 27.7 | % | ||||||||
% of net sales - Non-GAAP | 30.3 | % | 28.0 | % | 26.5 | % | 25.5 | % | ||||||||
Operating income - GAAP | $ | 105,904 | $ | 130,217 | $ | 654,855 | $ | 587,336 | ||||||||
Share-based compensation expense | 13,846 | 18,697 | 89,913 | 82,889 | ||||||||||||
Amortization of intangible assets and acquisition-related costs | 4,840 | 5,114 | 20,249 | 21,962 | ||||||||||||
Impairment of intangible assets | — | 3,526 | — | 3,526 | ||||||||||||
Change in fair value of contingent consideration for business acquisition | — | (250 | ) | — | (250 | ) | ||||||||||
Restructuring charges, net | 8,890 | 1,304 | 9,615 | 3,866 | ||||||||||||
Operating income - Non-GAAP | $ | 133,480 | $ | 158,608 | $ | 774,632 | $ | 699,329 | ||||||||
% of net sales - GAAP | 10.5 | % | 12.9 | % | 14.4 | % | 13.7 | % | ||||||||
% of net sales - Non-GAAP | 13.2 | % | 15.7 | % | 17.0 | % | 16.3 | % | ||||||||
Net income - GAAP | $ | 144,066 | $ | 167,615 | $ | 631,529 | $ | 612,143 | ||||||||
Share-based compensation expense | 13,846 | 18,697 | 89,913 | 82,889 | ||||||||||||
Amortization of intangible assets and acquisition-related costs | 4,840 | 5,114 | 20,249 | 21,962 | ||||||||||||
Impairment of intangible assets | — | 3,526 | — | 3,526 | ||||||||||||
Change in fair value of contingent consideration for business acquisition | — | (250 | ) | — | (250 | ) | ||||||||||
Restructuring charges, net | 8,890 | 1,304 | 9,615 | 3,866 | ||||||||||||
Loss on investments | 311 | 2,461 | 2,029 | 14,674 | ||||||||||||
Non-GAAP income tax adjustment | (32,225 | ) | (44,039 | ) | (13,405 | ) | (66,073 | ) | ||||||||
Net income - Non-GAAP | $ | 139,728 | $ | 154,428 | $ | 739,930 | $ | 672,737 | ||||||||
Net income per share: | ||||||||||||||||
Diluted - GAAP | $ | 0.96 | $ | 1.07 | $ | 4.13 | $ | 3.87 | ||||||||
Diluted - Non-GAAP | $ | 0.93 | $ | 0.99 | $ | 4.84 | $ | 4.25 | ||||||||
Shares used to compute net income per share: | ||||||||||||||||
Diluted - GAAP and Non-GAAP | 150,709 | 156,204 | 152,784 | 158,171 | ||||||||||||
LOGITECH INTERNATIONAL S.A. | ||||||||||||||||
PRELIMINARY RESULTS* | ||||||||||||||||
(In thousands) - unaudited | ||||||||||||||||
SUPPLEMENTAL FINANCIAL INFORMATION | ||||||||||||||||
Three Months Ended | Fiscal Years Ended | |||||||||||||||
March 31, | March 31, | |||||||||||||||
SHARE-BASED COMPENSATION EXPENSE | 2025 | 2024 | 2025 | 2024 | ||||||||||||
Share-based Compensation Expense | ||||||||||||||||
Cost of goods sold | $ | 1,348 | $ | 1,938 | $ | 10,021 | $ | 8,004 | ||||||||
Marketing and selling | 6,245 | 7,157 | 40,378 | 35,780 | ||||||||||||
Research and development | 4,331 | 4,268 | 20,180 | 17,836 | ||||||||||||
General and administrative | 1,922 | 5,334 | 19,334 | 21,269 | ||||||||||||
Total share-based compensation expense | 13,846 | 18,697 | 89,913 | 82,889 | ||||||||||||
Income tax benefit | (3,247 | ) | (4,048 | ) | (20,148 | ) | (15,305 | ) | ||||||||
Total share-based compensation expense, net of income tax benefit | $ | 10,599 | $ | 14,649 | $ | 69,765 | $ | 67,584 | ||||||||
*Note: These preliminary results for the three months and fiscal year ended March 31, 2025 are subject to adjustments, including subsequent events that may occur through the date of filing our Annual Report on Form 10-K.
(A) Non-GAAP Financial Measures
To supplement our condensed consolidated financial results prepared in accordance with GAAP, we use a number of financial measures, both GAAP and non-GAAP, in analyzing and assessing our overall business performance, for making operating decisions and for forecasting and planning future periods. We consider the use of non-GAAP financial measures helpful in assessing our current financial performance, ongoing operations and prospects for the future as well as understanding financial and business trends relating to our financial condition and results of operations.
While we use non-GAAP financial measures as a tool to enhance our understanding of certain aspects of our financial performance and to provide incremental insight into the underlying factors and trends affecting both our performance and our cash-generating potential, we do not consider these measures to be a substitute for, or superior to, the information provided by GAAP financial measures. Consistent with this approach, we believe that disclosing non-GAAP financial measures to the readers of our financial statements provides useful supplemental data that, while not a substitute for GAAP financial measures, can offer insight in the review of our financial and operational performance and enables investors to more fully understand trends in our current and future performance. In assessing our business during the quarter and fiscal year ended March 31, 2025 and prior periods presented, we excluded items in the following general categories, each of which are described below:
Share-based compensation expense. We believe that providing non-GAAP measures excluding share-based compensation expense, in addition to the GAAP measures, allows for a more transparent comparison of our financial results from period to period. We prepare and maintain our budgets and forecasts for future periods on a basis consistent with this non-GAAP financial measure. Further, companies use a variety of types of equity awards as well as a variety of methodologies, assumptions and estimates to determine share-based compensation expense. We believe that excluding share-based compensation expense enhances our ability and the ability of investors to understand the impact of non-cash share-based compensation on our operating results and to compare our results against the results of other companies.
Amortization of intangible assets. We incur intangible asset amortization expense, primarily in connection with our acquisitions of various businesses and technologies. The amortization of purchased intangibles varies depending on the level of acquisition activity. We exclude these various charges in budgeting, planning and forecasting future periods and we believe that providing the non-GAAP measures excluding these various non-cash charges, as well as the GAAP measures, provides additional insight when comparing our gross profit, operating expenses, and financial results from period to period.
Impairment of intangible assets. We may incur impairment of intangible assets expense, primarily in connection with our past business or asset acquisitions. We believe that providing the non-GAAP measures excluding these items, as well as the GAAP measures, assists our investors because such expenses are not reflective of our ongoing operating results.
Acquisition-related costs and change in fair value of contingent consideration for business acquisition. We incurred expenses and credits in connection with our acquisitions which we generally would not have otherwise incurred in the periods presented as a part of our continuing operations. Acquisition-related costs include certain incremental expenses incurred to effect a business combination. Fair value of contingent consideration is associated with our estimates of the value of earn-outs in connection with certain acquisitions. We believe that providing the non-GAAP measures excluding these costs and credits, as well as the GAAP measures, assists our investors because such costs are not reflective of our ongoing operating results.
Restructuring charges (credits), net. These charges (credits) are associated with restructuring plans, and will vary based on the initiatives in place during any given period. Restructuring charges may include costs related to employee terminations, facility closures and early cancellation of certain contracts as well as other costs resulting from our restructuring initiatives. We believe that providing the non-GAAP measures excluding these items, as well as the GAAP measures, assists our investors because such charges (credits) are not reflective of our ongoing operating results.
Loss (gain) on investments. We recognize losses (gains) related to our investments in various companies, which vary depending on the operational and financial performance of the companies in which we invest. These amounts include our losses (earnings) on equity method investments, investment impairments and losses (gains) resulting from sales or other events related to our investments. We believe that providing the non-GAAP measures excluding these items, as well as the GAAP measures, assists our investors because such losses (gains) are not reflective of our ongoing operations.
Non-GAAP income tax adjustment. Non-GAAP income tax adjustment primarily measures the income tax effect of non-GAAP adjustments excluded above as well as the income tax impact of non-recurring deferred taxes, tax settlements, and other non-routine tax events, the determination of which is based upon the nature of the underlying items. For the fiscal year ended March 31, 2025, non-GAAP income tax adjustment included the tax benefit from a remeasurement of the tax basis of goodwill under the Swiss Federal Act on Tax Reform and AHV Financing (“TRAF”).
Each of the non-GAAP financial measures described above, and used in this press release, should not be considered in isolation from, or as a substitute for, a measure of financial performance prepared in accordance with GAAP. Further, investors are cautioned that there are inherent limitations associated with the use of each of these non-GAAP financial measures as an analytical tool. In particular, these non-GAAP financial measures are not based on a comprehensive set of accounting rules or principles and many of the adjustments to the GAAP financial measures reflect the exclusion of items that are recurring and may be reflected in the Company’s financial results for the foreseeable future. We compensate for these limitations by providing specific information in the reconciliation included in this press release regarding the GAAP amounts excluded from the non-GAAP financial measures. In addition, as noted above, we evaluate the non-GAAP financial measures together with the most directly comparable GAAP financial information.
Additional Supplemental Financial Information - Constant Currency
In addition, Logitech presents percentage sales growth in constant currency to show performance unaffected by fluctuations in currency exchange rates. Percentage sales growth in constant currency is calculated by translating prior period sales in each local currency at the current period’s average exchange rate for that currency and comparing that to current period sales.
(LOGIIR)
View source version on businesswire.com: https://www.businesswire.com/news/home/20250429221652/en/
Contacts
Editorial Contacts:
Kate Beerkens, Director of Investor Relations - ir@logitech.com
Nicole Kenyon, Head of Global Communications - nkenyon@logitech.com (USA)
Ben Starkie, Corporate Communications - +41 (0)79-292-3499,
bstarkie1@logitech.com (Europe/AP)
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press Release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press Release
Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press Release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press Release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press Release
Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom